For instance; cancer antigen 125 (CA-125) for ovarian cancer [40]; CA-11-19 for colorectal cancer [41], CA-19-9 for lung cancer [42], and CA-15-3 for breast cancer [43], are well established markers in clinical practice. This evidence concerns the gene MUC16 and lung cancer.